Sinew Pharma Inc. (6634.TWO)
TWD 34.95
(-26.65%)
TWD 34.95
(-26.65%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -163.63 Million TWD | -39.75% |
| 2022 | -117.09 Million TWD | -70.23% |
| 2021 | -68.78 Million TWD | -14.87% |
| 2020 | -59.88 Million TWD | -3.61% |
| 2019 | -57.79 Million TWD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -35.77 Thousand TWD | 29.52% |
| 2024 Q2 | -35.77 Thousand TWD | 0.0% |
| 2023 Q4 | -50.75 Thousand TWD | 0.0% |
| 2023 Q2 | -31.05 Thousand TWD | 0.0% |
| 2023 Q3 | -50.75 Thousand TWD | -63.42% |
| 2023 Q1 | -31.05 Thousand TWD | 15.93% |
| 2022 FY | - TWD | -70.23% |
| 2022 Q4 | -36.94 Thousand TWD | 0.0% |
| 2021 FY | - TWD | -14.87% |
| 2020 FY | - TWD | -3.61% |
| 2019 FY | - TWD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | -46.24 Million TWD | -253.843% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 393.6 Million TWD | 141.572% |
| Level Biotechnology Inc. | 98.7 Million TWD | 265.78% |
| Sagittarius Life Science Corp | -44.73 Million TWD | -265.746% |
| NeoCore Technology Co., Ltd. | -72.11 Million TWD | -126.903% |
| TaiMed Biologics Inc. | -25.23 Million TWD | -548.48% |
| GlycoNex Incorporation | -126.82 Million TWD | -29.019% |
| VBI | -6.97 Million TWD | -2246.974% |
| GeneReach Biotechnology Corp. | -143.69 Million TWD | -13.874% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 21.81 Million TWD | 850.257% |
| SynCore Biotechnology Co.,Ltd | -17.72 Million TWD | -823.113% |
| Genomics BioSci & Tech. Co.,Ltd. | -103.61 Million TWD | -57.922% |
| Visgeneer Inc. | 973 Thousand TWD | 16917.163% |
| Mycenax Biotech Inc. | -339.48 Million TWD | 51.8% |
| Sunmax Biotechnology Co., Ltd. | 936.46 Million TWD | 117.473% |
| G&E Herbal Biotechnology Co., Ltd. | 99.83 Million TWD | 263.898% |
| Neith Corporation | -33.61 Million TWD | -386.852% |
| Medigen Vaccine Biologics Corporation | -991.09 Million TWD | 83.49% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -1.73 Million TWD | -9320.322% |
| Enimmune corporation | -228.96 Million TWD | 28.534% |
| TaiRx, Inc. | -208.64 Million TWD | 21.575% |
| CHO Pharma, Inc. | -277.73 Million TWD | 41.083% |
| EirGenix Inc. | -664.4 Million TWD | 75.372% |
| BioLASCO Taiwan Co., Ltd. | 73.9 Million TWD | 321.41% |
| Sunny Pharmtech Inc. | 69.14 Million TWD | 336.656% |
| Lin BioScience, Inc. | -1.07 Billion TWD | 84.727% |
| BioGend Therapeutics Co., Ltd. | -113.1 Million TWD | -44.67% |
| Feng Chi Biotech Corp. | 34.83 Million TWD | 569.691% |
| Bio Preventive Medicine Corp. | -62.34 Million TWD | -162.477% |
| Lukas Biomedical Inc. | -26.3 Million TWD | -522.171% |
| RBC Bioscience Corporation | 36.54 Million TWD | 547.728% |
| BiOptic Inc. | 65.03 Million TWD | 351.593% |
| BRIM Biotechnology, Inc. | -682.46 Million TWD | 76.023% |
| Shine-On BioMedical Co.,Ltd. | -33 Million TWD | -395.761% |
| Great Novel Therapeutics Biotech & Medicals | -54.91 Million TWD | -197.971% |
| Syngen Biotech Co.,Ltd. | 433.55 Million TWD | 137.742% |
| Advagene Biopharma Co., Ltd. | -80.07 Million TWD | -104.355% |
| NaviFUS Corp. | -55.79 Million TWD | -193.272% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -16.59 Million TWD | -885.848% |
| Andros Pharmaceuticals Co.,Ltd | -61.5 Million TWD | -166.067% |
| Greenyn Biotechnology Co., Ltd | 192.4 Million TWD | 185.046% |
| Lumosa Therapeutics Co., Ltd. | -226.67 Million TWD | 27.813% |
| AP Biosciences Inc | -325.51 Million TWD | 49.731% |
| Medigen Biotechnology Corp. | -1.04 Billion TWD | 84.336% |
| 3D Global Biotech Inc. | -35.84 Million TWD | -356.483% |
| Pharmosa Biopharm Inc. | 29.13 Million TWD | 661.727% |
| Intech Biopharm Corporation | -219.58 Million TWD | 25.482% |
| Oneness Biotech Co., Ltd. | -674.22 Million TWD | 75.731% |
| Eusol Biotech Co.,Ltd. | -44.95 Million TWD | -264.021% |
| TWi Biotechnology, Inc. | -160.85 Million TWD | -1.725% |
| Ever Supreme Bio Technology Co., Ltd | 655.52 Million TWD | 124.962% |
| TCI GENE Inc. | 25.98 Million TWD | 729.81% |
| MegaPro Biomedical Co., Ltd | -110.63 Million TWD | -47.898% |
| Senhwa Biosciences, Inc. | -283.78 Million TWD | 42.34% |
| Taiwan Bio Therapeutics Co., Ltd | -145.97 Million TWD | -12.099% |
| NatureWise Biotech & Medicals Corporation | 13.85 Million TWD | 1281.451% |
| PharmaEngine, Inc. | 347.3 Million TWD | 147.114% |
| Savior Lifetec Corporation | 219.6 Million TWD | 174.512% |
| TaiGen Biopharmaceuticals Holdings Limited | 172.23 Million TWD | 195.007% |
| OBI Pharma, Inc. | -855.08 Million TWD | 80.864% |
| Meribank Biotech Co., Ltd | -92.56 Million TWD | -76.778% |
| Acepodia, Inc. | -764.51 Million TWD | 78.597% |
| Caliway Biopharmaceuticals Co., Ltd. | -460.09 Million TWD | 64.435% |